94 results on '"Hao D"'
Search Results
2. EP08.04-01 Predictors and Outcomes of Pneumonitis in Non-Small Cell Lung Cancer Patients treated with Consolidative Durvalumab
3. Effect of Pd addition in BNi-2 interlayer on microstructure and properties in the TLP joints of FeCoNiTiAl and FGH98 alloys
4. Adjusting solar-induced fluorescence to nadir-viewing provides a better proxy for GPP
5. A CT-based radiomics nomogram for distinguishing between malignant and benign Bosniak IIF masses: a two-centre study
6. Exosomes/EVs: CONJUGATION OF A HIGH-AFFINITY INTEGRIN LIGAND TO THE SURFACE OF STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR TARGETED DELIVERY
7. Fabrication of AgI/Ce-2MI Z-scheme heterojunction for enhanced photoreduction of Cr(VI) under visible light irradiation
8. Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial
9. EP06.01-003 Impact of COVID-19 on Lung Cancer Patients; The Patients’ Perspective
10. EP08.02-014 Impact of East Asian Ancestry on Response to First-Line Osimertinib: A Real-World Canadian Cohort
11. EP10.01-008 Examining Social Determinants of Health Among Newly Diagnosed Lung Cancer Patients Contacted for Early Specialist Palliative Care Consultation
12. EP04.02-004 The Patient Impact of Liquid Biopsy - Health-Related Quality of Life in Patients Undergoing Liquid Biopsy for Advanced Non-Small Cell Lung Cancer
13. 505P The impact of COVID-19 on the wellness and resilience of the Canadian medical oncology workforce: A Canadian Association of Medical Oncologists survey
14. Practical approaches for normalizing directional solar-induced fluorescence to a standard viewing geometry
15. PCR16 Stroke Rehabilitation Treatment Preferences of Chinese Physicians and Patients during the COVID-19 Pandemic: A Discrete Choice Experiment
16. Technique to manage intraoperative cuff leak from damaged endotracheal tube pilot balloon
17. OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
18. OA05.02 Acceptability of Automatic Referrals to Supportive and Palliative Care, by Patients Living with Advanced Lung Cancer: A Co-Design Process
19. Standard diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MRI of musculoskeletal tumours: correlations with Ki67 proliferation status
20. 1606P Impact of COVID-19 (SARS-CoV-2, C19) on medical oncologists (MOs) and cancer care: A Canadian Association of Medical Oncologists (CAMO) survey study
21. 904P ACCURACY: A phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut): Results of 6-mg cohort
22. PSU13 Effects of Certain Ingredients in Iron Supplements or Iron-Fortified Foods on Diarrhea in Infants Younger THAN 1 Year of Age: A Systematic Review and Meta-Analysis
23. PIN30 Comparing Two Rotavirus Vaccines Strategies Versus NO Vaccine in China- a Cost-Effectiveness Analysis
24. PIN41 The Public Health Implications of Google Trends and News Coverage for COVID-19 in the Early Epidemic Stage: A Multinational Study in Eight Countries
25. PDB28 Innovative Application of a Mobile APP for Gestational Diabetes Health Education in the Era of the COVID-19 Pandemic and BIG DATA
26. P89.12 Real World Outcomes in EGFR-Mutant Relapsed and De Novo Stage IV Non-Small Cell Lung Cancer (NSCLC)
27. P89.03 Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System
28. Coupling iron pretreatment with a constructed wetland-microbial fuel cell to improve wastewater purification and bioelectricity generation
29. Radiomics-based machine-learning method for prediction of distant metastasis from soft-tissue sarcomas
30. Repair of facial scars using free and pedicle-expanded deltopectoral flaps
31. Use of convalescent plasma therapy in eight individuals with mild COVID-19
32. Controllable design of nanoworm-like nickel sulfides for efficient electrochemical water splitting in alkaline media
33. 400P Sequential afatinib and osimertinib in real-world EGFR mutation positive (EGFRm+) NSCLC: Final analysis of Asian patients in the GioTag study
34. 1195P The value of detecting resistance through liquid biopsy
35. IgG Fc glycosylation as an axis of humoral immunity in childhood
36. Survie globale des patients atteints de CBNPC EGFRm+ recevant la séquence de traitement afatinib suivi d’osimertinib : analyse actualisée de l’étude GioTag
37. Feasibility of three-dimensional constructive interference in steady state sequences for evaluating the anterolateral ligament
38. OA03.09 Overall Survival in Patients with EGFRM+ NSCLC Receiving Sequential Afatinib and Osimertinib: an Update of the Giotag Study
39. Overall survival in patients with EGFRm+ NSCLC receiving sequential afatinib and osimertinib: Updated analysis of the GioTag study
40. PD2.05 Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study
41. Afatinib followed by osimertinib in patients with EGFR mutation-positive (EGFRm+) advanced NSCLC: Updated data from the GioTag real-world study
42. P1.01-118 Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study
43. P1.16-33 From a Systematic Review to Real World Evidence: Integrating Gender as a Clinical Risk Factor in NSCLC
44. Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy
45. MA11.04 Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226
46. A Real World Comparison of Cisplatin Versus Cetuximab Used Concurrently with Radiation in the Treatment of Locally Advanced Oropharyngeal Carcinoma
47. Afatinib suivi d’osimertinib en vie réelle chez des patients avec CBNPC avancé EGFR muté : étude GioTag
48. Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
49. OA03 Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
50. Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.